ATE548651T1 - Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren - Google Patents

Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren

Info

Publication number
ATE548651T1
ATE548651T1 AT06773407T AT06773407T ATE548651T1 AT E548651 T1 ATE548651 T1 AT E548651T1 AT 06773407 T AT06773407 T AT 06773407T AT 06773407 T AT06773407 T AT 06773407T AT E548651 T1 ATE548651 T1 AT E548651T1
Authority
AT
Austria
Prior art keywords
classification
mass spectra
cellular samples
chemically cross
linked cellular
Prior art date
Application number
AT06773407T
Other languages
English (en)
Inventor
Conklin Bathsheba E Chong
Patrick J Parks
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Application granted granted Critical
Publication of ATE548651T1 publication Critical patent/ATE548651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
AT06773407T 2005-06-16 2006-06-16 Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren ATE548651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69118205P 2005-06-16 2005-06-16
PCT/US2006/023594 WO2006138629A2 (en) 2005-06-16 2006-06-16 Method of classifying chemically crosslinked cellular samples using mass spectra

Publications (1)

Publication Number Publication Date
ATE548651T1 true ATE548651T1 (de) 2012-03-15

Family

ID=37571252

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06773407T ATE548651T1 (de) 2005-06-16 2006-06-16 Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren

Country Status (6)

Country Link
US (1) US20110177492A1 (de)
EP (1) EP1891433B1 (de)
JP (2) JP2008547005A (de)
AT (1) ATE548651T1 (de)
AU (1) AU2006261624B2 (de)
WO (1) WO2006138629A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
JP2008547005A (ja) * 2005-06-16 2008-12-25 スリーエム イノベイティブ プロパティズ カンパニー マススペクトルを用いた化学的に架橋された細胞サンプルの分類方法
US20100075372A1 (en) * 2006-09-28 2010-03-25 Taka-Aki Sato Method for deparaffinization of paraffin-embedded specimen and method for analysis of paraffin-embedded specimen
EP2235541A2 (de) * 2007-12-13 2010-10-06 3M Innovative Properties Company Verfahren zur analyse von wundproben
EP2073011A1 (de) * 2007-12-20 2009-06-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mittel und Verfahren zur Verarbeitung biologischer Proben
EP3832658A1 (de) * 2011-08-03 2021-06-09 QIAGEN Redwood City, Inc. Verfahren und systeme zur analyse biologischer daten
JP6759104B2 (ja) 2014-04-04 2020-09-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精密分子質量を用いた免疫グロブリンのアイソタイピング
EP3175242A4 (de) 2014-07-29 2017-12-27 Mayo Foundation for Medical Education and Research Quantifizierung monoklonaler antikörpertherapeutika durch lc-ms/ms
WO2017053932A1 (en) 2015-09-24 2017-03-30 Mayo Foundation For Medical Education And Research Identification of immunoglobulin free light chains by mass spectrometry
US10955420B2 (en) 2016-09-07 2021-03-23 Mayo Foundation For Medical Education And Research Identification and monitoring of cleaved immunoglobulins by molecular mass
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
CN112444479B (zh) * 2021-02-01 2021-05-07 宁波大学 基于并行处理技术的单细胞质谱分析系统及方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304705A (en) * 1980-01-02 1981-12-08 Minnesota Mining And Manufacturing Company Radiation-curable polymers containing pendant unsaturated peptide groups derived from azlactone polymers
US4507233A (en) * 1981-04-22 1985-03-26 Oriental Yeast Co., Ltd. Colored molecular weight marker
US4545831A (en) * 1982-09-13 1985-10-08 The Mount Sinai School Of Medicine Method for transferring a thin tissue section
US4485236A (en) * 1982-09-27 1984-11-27 Minnesota Mining And Manufacturing Company Azlactone-functional compounds
US5258041A (en) * 1982-09-29 1993-11-02 Bio-Metric Systems, Inc. Method of biomolecule attachment to hydrophobic surfaces
US4451619A (en) * 1982-09-30 1984-05-29 Minnesota Mining And Manufacturing Company Method of hydrophilizing or hydrophobizing polymers
US4820504A (en) * 1986-02-12 1989-04-11 City Of Hope Multi-specimen tissue blocks and slides
US5336742A (en) * 1987-03-13 1994-08-09 Minnesota Mining And Manufacturing Company Polymeric supports
US5204219A (en) * 1987-07-30 1993-04-20 Minnesota Mining And Manufacturing Company Photographic element with novel subbing layer
US5753437A (en) * 1987-10-13 1998-05-19 The United States Of America As Represented By The Department Of Health & Human Services Method of diagnosing cancer susceptibility or metastatic potential
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
US4914022A (en) * 1987-10-21 1990-04-03 Amc Cancer Research Center Method for preparing multiple tissue samples for microscopic investigation and testing
US5262484A (en) * 1989-04-10 1993-11-16 Minnesota Mining And Manufacturing Company Azlactone graft copolymers
US5149806A (en) * 1990-03-28 1992-09-22 Minnesota Mining And Manufacturing Company Azlactone michael adducts
US5436147A (en) * 1991-03-01 1995-07-25 Nucleic Assays Corporation Heterobifunctional crosslinked agents for immobilizing molecules on plastic substrates
US5639546A (en) * 1991-09-03 1997-06-17 Minnesota Mining And Manufacturing Company Coated article having improved adhesion to organic coatings
US5500251A (en) * 1992-05-01 1996-03-19 Air Products And Chemicals, Inc. Process for coating low energy surfaces
US5489508A (en) * 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5344701A (en) * 1992-06-09 1994-09-06 Minnesota Mining And Manufacturing Company Porous supports having azlactone-functional surfaces
US5464900A (en) * 1993-10-19 1995-11-07 Minnesota Mining And Manufacturing Company Water soluble organosiloxane compounds
US5602202A (en) * 1994-01-14 1997-02-11 Minnesota Mining And Manufacturing Company Methods of using acrylate-containing polymer blends
US6251516B1 (en) * 1994-03-01 2001-06-26 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
US5843657A (en) * 1994-03-01 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
US5843644A (en) * 1994-03-01 1998-12-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation of cellular material under microscopic visualization using an adhesive/extraction reagent tipped probe
US6251467B1 (en) * 1994-03-01 2001-06-26 The United States Of America As Represented By The Department Of Health And Human Services Isolation of cellular material under microscopic visualization
US5728915A (en) * 1995-05-08 1998-03-17 Children's Hospital, Inc. Transgenic mice which express simian SV 40 T-antigen under control of the retinoblastoma gene promoter
FR2740777B1 (fr) * 1995-11-02 1998-01-02 Hutchinson Films d'elastomere contenant au moins une substance chimique active, leur procede de preparation et leurs applications
US6177266B1 (en) * 1996-04-29 2001-01-23 The United States Of America As Represented By The Secretary Of The Army Rapid identification of bacteria by mass spectrometry
US6376619B1 (en) * 1998-04-13 2002-04-23 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same
KR100713786B1 (ko) * 1999-04-27 2007-05-07 바이오 래드 래버러토리스 인코오포레이티드 기체상 이온 분광계용 탐침
US6136592A (en) * 1999-06-25 2000-10-24 Leighton; Stephen B. Multiple micro-arrays
US6395483B1 (en) * 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers
US6690470B1 (en) * 1999-11-04 2004-02-10 Arcturus Engineering, Inc. Automated laser capture microdissection
PT1276486E (pt) * 2000-04-25 2011-02-07 Osiris Therapeutics Inc Reparação de articulação utilizando células estaminais do mesênquima
EP1305595A2 (de) * 2000-06-22 2003-05-02 Clinomics Laboratories, Inc. Mikroarrays aus eingefrorenem gewebe und verfahren zu ihrer verwendung
ATE540421T1 (de) * 2000-11-16 2012-01-15 Bio Rad Laboratories Methode zum analysieren von massenspektren
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US6756586B2 (en) * 2001-10-15 2004-06-29 Vanderbilt University Methods and apparatus for analyzing biological samples by mass spectrometry
CA2505921A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
DK1601450T3 (da) * 2003-03-10 2013-09-08 Expression Pathology Inc Flydende vævspræparat ud fra histopatologisk bearbejdede biologiske prøver, væv og celler
WO2004088325A2 (en) * 2003-03-26 2004-10-14 President And Fellows Of Harvard College Determination of proteins and/or other molecules using mass spectroscopy
US8012693B2 (en) * 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
WO2006127861A2 (en) * 2005-05-25 2006-11-30 Expression Pathology, Inc. Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
JP5166250B2 (ja) * 2005-05-25 2013-03-21 エクスプレッション、パソロジー、インコーポレイテッド 組織病理学的に処理した生物学的試料からのプロテオームの適用範囲を増加させるための、液体組織標品を用いたマルチプレックス方法
JP2008547005A (ja) * 2005-06-16 2008-12-25 スリーエム イノベイティブ プロパティズ カンパニー マススペクトルを用いた化学的に架橋された細胞サンプルの分類方法

Also Published As

Publication number Publication date
AU2006261624A1 (en) 2006-12-28
JP2008547005A (ja) 2008-12-25
WO2006138629A2 (en) 2006-12-28
WO2006138629A3 (en) 2007-08-23
AU2006261624B2 (en) 2012-02-02
EP1891433A2 (de) 2008-02-27
JP2012185170A (ja) 2012-09-27
JP5624079B2 (ja) 2014-11-12
EP1891433B1 (de) 2012-03-07
US20110177492A1 (en) 2011-07-21
EP1891433A4 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
ATE548651T1 (de) Verfahren zur klassifizierung chemisch quervernetzter zellulärer proben unter verwendung von massenspektren
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
MY145833A (en) Micro-hydrocarbon analysis
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
ATE475171T1 (de) Verfahren und vorrichtung zur erkennung tonaler komponenten von audiosignalen
EP1820021B8 (de) Verbessertes verfahren zur elektrochemischen analyse eines analyten
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
EP1867978A4 (de) Verfahren zur analytanalyse und analytanalysegerät
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
DE60305778D1 (de) Vorrichtung zur Probenvorbehandlung
ATE545031T1 (de) Verfahren unter beteiligung von datenmustern, wie etwa spektralen biomarkern
ATE470722T1 (de) Strategien zur genexpressionsanalyse
DE602006021689D1 (de) Bodenplatte zur Verwendung bei der Massenspektrometrieanalyse sowie Verfahren und Vorrichtung zur Massenspektrometrieanalyse
WO2006060799A3 (en) Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis
HK1118337A1 (en) Methods for altering one or more parameters of a measurement system
WO2006047662A3 (en) Method and apparatus for sediment characterization
DE502006006970D1 (de) Verfahren zur Vorbereitung von Proben für ein Analysegerät und Probennahmenstation hierfür
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2007044071A3 (en) Analysis of heterogeneous nucleic acid samples
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
SG127861A1 (en) in situ biomarker identification
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
DK1951395T3 (da) Fremgangsmåde til kvantitativ bestemmelse af poloxamerer
GB0510881D0 (en) System and method for analysing laboratory samples
DE50105263D1 (de) Verfahren zur analyse von proteinen